Literature DB >> 7708961

Potential pitfalls in the use of p-values and in interpretation of significance levels.

H P Beck-Bornholdt1, H H Dubben.   

Abstract

In multiparameter analysis of clinical data the likelihood of obtaining significant results, just by chance, increases considerably with the overall number of tests performed. This can be compensated for by adjusting the p-values. Two tables are given from which adjusted p-values may be read off, providing a simple procedure to test the reliability of the results from clinical studies. Multivariate analyses often impress with extremely low p-values, but frequently these results turn out to be non-significant when the influence of multiple testing is considered. As a consequence the actually relevant results might be overlooked, because of the large number of spurious results accumulating in the literature. The use of inappropriate statistics hampers progress in clinical research. It is concluded that more care in the use of p-values in analysis and interpretation of clinical data is required.

Mesh:

Year:  1994        PMID: 7708961     DOI: 10.1016/0167-8140(94)90072-8

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  12 in total

1.  Factors affecting survival time after recurrence of non-small-cell lung cancer treated with concurrent chemoradiotherapy.

Authors:  Yasushi Hamamoto; Masaaki Kataoka; Naoyuki Nogami; Toshiyuki Kozuki; Yuka Kato; Shuichi Shinohara; Tetsu Shinkai
Journal:  Jpn J Radiol       Date:  2012-02-07       Impact factor: 2.374

2.  Disease control using low-dose-rate brachytherapy is unaffected by comorbid severity in oral cancer patients.

Authors:  R Yoshimura; H Shibuya; K Hayashi; K Toda; H Watanabe; M Miura
Journal:  Br J Radiol       Date:  2011-01-11       Impact factor: 3.039

3.  Second look at the potential use of ginseng berry extract for treating erectile dysfunction.

Authors:  D C Watson
Journal:  Int J Impot Res       Date:  2014 May-Jun       Impact factor: 2.896

4.  High-dose rate intracavitary irradiation for carcinoma of the uterine cervix. The adverse effect of treatment prolongation.

Authors:  M Chatani; Y Matayoshi; N Masaki; T Inoue
Journal:  Strahlenther Onkol       Date:  1997-07       Impact factor: 3.621

5.  Radiation therapy for early glottic carcinoma (T1N0M0). The adverse effect of treatment interruption.

Authors:  M Chatani; Y Matayoshi; N Masaki; T Teshima; T Inoue
Journal:  Strahlenther Onkol       Date:  1997-10       Impact factor: 3.621

6.  [Combined breast-preserving surgery, chemotherapy and radiotherapy in the treatment of breast carcinoma. Effect of the interval between surgery and the beginning of radiotherapy].

Authors:  H Willers; F Würschmidt; I Janik; H Bünemann; H P Heilmann
Journal:  Strahlenther Onkol       Date:  1997-03       Impact factor: 3.621

7.  [Soft tissue sarcoma of the head and neck area in adults. Outcome of combined surgery and irradiation and radiotherapy alone].

Authors:  H Willers; E B Hug; I J Spiro; J T Efird; A E Rosenberg; C C Wang
Journal:  Strahlenther Onkol       Date:  1997-03       Impact factor: 3.621

8.  Validation of the Medical Research Council and a newly developed prognostic index in patients with malignant glioma: how useful are prognostic indices in routine clinical practice?

Authors:  Fadime Akman; Rachel A Cooper; Mehmet Sen; Yildiray Tanriver; Süleyman Kentli
Journal:  J Neurooncol       Date:  2002-08       Impact factor: 4.130

9.  [The results of radiotherapy in meningiomas with a high risk of recurrence. A retrospective analysis].

Authors:  C Winkler; S Dornfeld; R Schwarz; S Friedrich; M Baumann
Journal:  Strahlenther Onkol       Date:  1998-12       Impact factor: 3.621

10.  Adjuvant radiotherapy after radical hysterectomy of the cervical cancer. Prognostic factors and complications.

Authors:  M Chatani; T Nose; N Masaki; T Inoue
Journal:  Strahlenther Onkol       Date:  1998-10       Impact factor: 3.621

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.